Velan Capital Investment Management »

ImmunoGen shares owned by Velan Capital Investment Management

Quarter-by-quarter ownership of ImmunoGen shares owned by Velan Capital Investment Management from 13F filings

Historical chart of Velan Capital Investment Management investment in ImmunoGen

Tip: Access up to 7 years of quarterly data

All positions including ImmunoGen held by Velan Capital Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ImmunoGen by Velan Capital Investment Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $3.0M 190k 15.87
2023-06-30 $3.6M 190k 18.87

More positions owned by Velan Capital Investment Management

Alimera Sciences Com New (ALIM)
Praxis Precision Medicines I
Heron Therapeutics (HRTX)
Jasper Therapeutics
Adma Biologics (ADMA)
Quipt Home Medical Corporation Call Option (QIPT)
Tela Bio (TELA)
Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH)
Optinose (OPTN)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Inspire Med Sys (INSP)
ImmunoGen
Inspiremd (NSPR)
Gossamer Bio (GOSS)
Cabaletta Bio (CABA)

View all positions for Velan Capital Investment Management

Top funds holding ImmunoGen

Vanguard Group
RA Capital Management
Redmile Group
Henderson Group
Pentwater Capital Management
Fairmount Funds Management
Norges Bank Investment Management
Millennium Management
D. E. Shaw & Co
Balyasny Asset Management
Voloridge Investment Management
Boxer Capital
Maverick Capital
TIG Advisors
Tang Capital Management

View all funds holding ImmunoGen